MedTrace Logo

OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory Arthritis

NCT02554474 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2024-01-30

Study results available
· View outcomes & findings →

Summary

Being physically active can reduce pain and fatigue, improve mobility and enhance quality of life in people with arthritis, but adherence to an active lifestyle is poor, with less than half of people with arthritis being active. The primary goal of this randomized controlled trial is to assess the efficacy of a physical activity coaching model to improve physical activity participation and reduce sedentary time in patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus. This model combines the use of a Fitbit Flex (wireless physical activity tracker) paired with a FitViz application, a group education session, and telephone counselling by a physiotherapist.

Conditions

Interventions

BEHAVIORAL

Education, Fitbit/FitViz, physiotherapist counselling.

Participants will receive a brief education session, use a physical activity tracker Fitbit Flex with paired with a FitViz app, and remote counseling by a PT. Intervention will be received immediately.

BEHAVIORAL

Same intervention with a 9-week delay

The Delayed Intervention Group will receive the same intervention as the Immediate Intervention Group, but with a 9-week delay.

Sponsors & Collaborators

  • Simon Fraser University

    collaborator OTHER

  • Arthritis Research Centre of Canada

    collaborator OTHER

  • Vancouver General Hospital

    collaborator OTHER

  • The Arthritis Society, Canada

    collaborator OTHER

  • Fraser Health

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Linda Li, PhD · Professor

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2019-08-25
Completion
2019-08-25

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02554474 on ClinicalTrials.gov